{"id":"W4410820775","doi":"10.1200/jco.2025.43.16_suppl.tps2096","title":"A global phase 3, open-label, randomized 2-arm study comparing the clinical efficacy and safety of niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Medicine; Glioblastoma; Phases of clinical research; Oncology; Internal medicine; Open label; Clinical trial; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003723173,0.002468941,0.002686792,0.0005517282,0.0005227139,0.0009816838,0.001172952,0.002093059,0.007163731],"category_scores_gemma":[0.001595164,0.0008082745,0.002089977,0.0005331386,0.001436546,0.001431247,0.0007064453,0.003833015,0.001616756],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008854319,"about_ca_system_score_gemma":0.00242513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000763643,"about_ca_topic_score_gemma":0.002327028,"domain_scores_codex":[0.998985,0.0005819011,0.00004072205,0.0001657662,0.00007132909,0.0001552715],"domain_scores_gemma":[0.9987178,0.0001934675,0.0002867062,0.0000983322,0.00009919345,0.0006046185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.940547,0.02528856,0.002612036,0.0005294887,0.001076884,0.00007656727,0.000109843,0.0004405201,0.008768446,0.0001104612,0.002208065,0.01823212],"study_design_scores_gemma":[0.7891118,0.2026902,0.00496116,0.00002410757,0.000386906,0.00009145295,0.0000332251,0.000290957,0.0007064945,0.0001751726,0.001505639,0.0000229037],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9673097,0.003469744,0.001685407,0.001061118,0.0003518176,0.01818629,0.00553184,0.0002828094,0.002121301],"genre_scores_gemma":[0.9464868,0.002635914,0.007481936,0.004825333,0.0004727025,0.02613624,0.007736743,0.0001205253,0.004103804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007163731,"threshold_uncertainty_score":0.02396506,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1259909948730169,"score_gpt":0.5039923030240893,"score_spread":0.3780013081510724,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}